Pacific Biosciences
PACB
PACB
262 hedge funds and large institutions have $5.47B invested in Pacific Biosciences in 2021 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 80 increasing their positions, 78 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
262
Holders Change
+52
Holders Change %
+24.76%
% of All Funds
4.61%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
81
Increased
80
Reduced
78
Closed
27
Calls
$70.1M
Puts
$29.6M
Net Calls
+$40.5M
Net Calls Change
+$39.8M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$592M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$99.1M |
| 3 |
Norges Bank
Oslo,
Norway
|
$55M |
| 4 |
Two Sigma Investments
New York
|
$47.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
$46.5M |
